Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

REBUILDER(TM)

K-Number: K874085 · 1987-12-11

Decision Date1987-12-11
Product CodeGZJ
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

REBUILDER(TM) is the device name listed in this FDA 510(k) record. The listed applicant is Micromed, Inc.. It received FDA 510(k) clearance on 1987-12-11 under 510(k) number K874085. The device is classified under product code GZJ. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the REBUILDER(TM)?

REBUILDER(TM) is a medical device that received FDA 510(k) clearance on 1987-12-11. The listed applicant is Micromed, Inc.. The 510(k) number is K874085.

When did REBUILDER(TM) receive FDA 510(k) clearance?

REBUILDER(TM) received FDA 510(k) clearance on 1987-12-11, under 510(k) number K874085.

Who is the listed applicant for REBUILDER(TM)?

The FDA 510(k) record lists Micromed, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for REBUILDER(TM)?

The FDA product code for REBUILDER(TM) is GZJ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Micromed, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: GZJ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑